Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 18,68118,700 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem
NATIONAL CANCER INSTITUTE University of Kansas Medical Center United States 2021 – 2026

PROJECT SUMMARY Ovarian cancer is a silent killer that strikes with few, if any, symptoms. By the time a woman knows she has it, the cancer is often advanced and the outlook grim....

$5.93M
USD
Completed NON-SBIR/STTR RPGS
Viscotaxis: Novel cell migration mechanisms regulated by microenvironmental viscosity
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2026

Cell motility is a key step in the metastatic cascade of events, as it enables cancerous cells dissociating from a primary tumor to navigate through interstitial tissues and ultima...

$4.59M
USD
Completed NON-SBIR/STTR RPGS
Understanding Efficacy and Fe(II)-Promoted Activation of 1,2,4-Trioxolanes in Cancer
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2024

Project Summary/Abstract Summary: Precision cancer medicine’s foundation lies in discovering and exploiting pathways that are essential for cancer cells, but dispensable for cancer...

$6.25M
USD
Completed NON-SBIR/STTR RPGS
Changing Contraceptive Patterns and Ovarian Cancer Risk
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2021 – 2026

ABSTRACT Contraceptive patterns are changing and the implications for ovarian cancer risk are unknown. Oral contraceptives (OCs), which are an established protective factor for ova...

$5.35M
USD
Completed NON-SBIR/STTR RPGS
Joint receptor and protein expression immunophenotyping through split-pool barcoding
NATIONAL CANCER INSTITUTE University of Washington United States 2021 – 2024

Single-cell immune repertoire sequencing can provide invaluable information about the response of the adaptive immune system to disease and therapy. However, existing approaches fo...

$3.96M
USD
Completed NON-SBIR/STTR RPGS
Remodeling of 3D chromatin in B cell acute leukemia and its impact on clinical outcome
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2021 – 2026

ABSTRACT While the outcomes for children with acute lymphoblastic leukemia (ALL) have improved dramatically over the past four decades, major challenges remain including the burden...

$4.36M
USD
Completed NON-SBIR/STTR RPGS
Mechanisms of Epigenetic Plasticity in PDAC
NATIONAL CANCER INSTITUTE Georgetown University United States 2021 – 2026

Pancreatic ductal adenocarcinoma (PDAC) is one of the most deadly human cancers and in ~95% of cases driven by oncogenic mutations of Kras. Unfortunately, attempts to directly inhi...

$4.83M
USD
Completed NON-SBIR/STTR RPGS
Understanding and exploiting novel therapeutic vulnerabilities of RIT1-driven lung cancer
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Recent advances in targeted therapies have revolutionized lung cancer clinical practice. Lung adenocarcinomas harbor frequent mutations/amplifications/fusi...

$4.58M
USD
Completed NON-SBIR/STTR RPGS
Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2023

PROJECT SUMMARY/ABSTRACT Chemotherapy induced peripheral neuropathy is a common dose-limiting toxicity that can reduce therapeutic effectiveness and impact quality of life for canc...

$1.55M
USD
Completed NON-SBIR/STTR RPGS
Exploring novel SRC-regulated pathways in IDH mutant intrahepatic cholangiocarcinoma
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Intrahepatic cholangiocarcinoma (ICC) is a highly lethal form of liver cancer which has been rising in incidence worldwide and carries a prognosis of under...

$3.95M
USD
Completed NON-SBIR/STTR RPGS
Understanding and targeting MAPK pathway activation in NF1-deficient malignant peripheral nerve sheath tumor (MPNST)
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2026

Project Abstract Malignant peripheral nerve sheath tumors (MPNSTs) represent a group of highly aggressive soft tissue sarcomas that occur in distinct clinical settings: neurofibrom...

$6.17M
USD
Completed SBIR-STTR RPGS
A Novel Microbiome-Based Immune-Modulator that Potentiates Cancer Checkpoint Therapy
NATIONAL CANCER INSTITUTE Rise Therapeutics, Llc United States 2021 – 2025

Project Summary The goal of this project is to develop a novel oral drug, R-5780, which engages microbiome-associated Pattern Recognition Receptors (PRRs) to enhance the activity o...

$8.28M
USD
Completed NON-SBIR/STTR RPGS
Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2021 – 2026

Project Summary/Abstract Pancreatic ductal adenocarcinoma (PDAC) has a dire prognosis mainly due to its late diagnosis. It is vital to identify early-stage PDAC and its precursors....

$6.28M
USD
Completed NON-SBIR/STTR RPGS
Human papillomavirus in HIV associated lung cancers
NATIONAL CANCER INSTITUTE Tulane University of Louisiana United States 2021 – 2026

SUMMARY In recent years, the incidence of AIDS-defining cancers has dramatically decreased due to the HAART therapy. In contrast, the incidence of the non-AIDS-defining cancers (NA...

$3.47M
USD
Completed NON-SBIR/STTR RPGS
Targeting allosteric scaffolding functions of Aurora kinase A in cancer
NATIONAL CANCER INSTITUTE University of Minnesota United States 2021 – 2026

ABSTRACT Neuroblastoma is the most common solid tumor in infants. About 25% of patients have high-risk neuroblastoma, a devastating disease with poor prognosis and few treatment op...

$3.37M
USD
Completed NON-SBIR/STTR RPGS
The selective advantage of mismatch repair loss in colonic stem cells
NATIONAL CANCER INSTITUTE University of Connecticut Sch of Med/Dnt United States 2021 – 2026

Project Summary Lynch syndrome (LS) is a hereditary disease that predisposes patients to colorectal, endometrial, ovarian and other cancers. LS is caused by inherited mutations in...

$4.23M
USD
Active NON-SBIR/STTR RPGS
Synthetic epigenetic circuits: tunable cell fate switches controlled by dynamic and combinatorial inputs
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2027

PROJECT SUMMARY Cellular differentiation is controlled by epigenetic regulatory systems that integrate multiple sensory inputs over time to direct long-term cell fate decisions. Ha...

$3.95M
USD
Completed NON-SBIR/STTR RPGS
Understanding the role of TP53 mutation in genetic susceptibility to ovarian cancer
NATIONAL CANCER INSTITUTE University of Washington United States 2021 – 2026

Project Summary Understanding the role of TP53 mutation in genetic susceptibility to ovarian cancer Women with germline mutations in BRCA1 and BRCA2 (BRCA carriers) are at high ris...

$4.84M
USD
Completed NON-SBIR/STTR RPGS
Predicting sensitivity and resistance in RET-driven cancers
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2026

Selpercatinib (LOXO-292) is a highly active selective RET inhibitor explored on an ongoing registrational program (LIBRETTO-001 phase 1/2 trial) in RET-dependent cancers (US FDA ap...

$3.85M
USD
Completed NON-SBIR/STTR RPGS
Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2026

PROJECT SUMMARY Chemotherapy-induced Peripheral Neuropathy (CIPN) is one of the most harmful, common, painful, and disabling side effects of many chemotherapy agents and there is n...

$3.07M
USD